Heme Queen
@heme-queen.bsky.social
Mother
Runner
Coffee-lover
Hematology fellow
#HemeSky #MedSky
Runner
Coffee-lover
Hematology fellow
#HemeSky #MedSky
Reposted by Heme Queen
One week left to apply for the HTRS Trainee Workshop Spring 2026!
Apply by Dec 15, 2025: www.htrs.org/continuing-p...
Apply by Dec 15, 2025: www.htrs.org/continuing-p...
December 8, 2025 at 6:04 PM
One week left to apply for the HTRS Trainee Workshop Spring 2026!
Apply by Dec 15, 2025: www.htrs.org/continuing-p...
Apply by Dec 15, 2025: www.htrs.org/continuing-p...
Reposted by Heme Queen
We are excited to welcome thirty medical trainees to Orlando, Florida, for the HTRS Trainee Workshop: Winter 2025. This year’s cohort will have the opportunity to learn from our distinguished faculty through an engaging and immersive program.
December 3, 2025 at 8:42 PM
We are excited to welcome thirty medical trainees to Orlando, Florida, for the HTRS Trainee Workshop: Winter 2025. This year’s cohort will have the opportunity to learn from our distinguished faculty through an engaging and immersive program.
Reposted by Heme Queen
🌍 Reminder: ASH International Outreach Initiative Applications Now Open!
The ASH IOI aims to bridge the gap in #hematology education by offering free educational resources to institutions in low- and middle-income countries.
🔗 https://bit.ly/4liN3yc
#HemeSky #MedSky
The ASH IOI aims to bridge the gap in #hematology education by offering free educational resources to institutions in low- and middle-income countries.
🔗 https://bit.ly/4liN3yc
#HemeSky #MedSky
October 22, 2025 at 11:05 AM
🌍 Reminder: ASH International Outreach Initiative Applications Now Open!
The ASH IOI aims to bridge the gap in #hematology education by offering free educational resources to institutions in low- and middle-income countries.
🔗 https://bit.ly/4liN3yc
#HemeSky #MedSky
The ASH IOI aims to bridge the gap in #hematology education by offering free educational resources to institutions in low- and middle-income countries.
🔗 https://bit.ly/4liN3yc
#HemeSky #MedSky
Reposted by Heme Queen
PCP has pt on 4 agents for sleep/RLS…has never checked iron…ferritin of 6…what are we doing chat
October 23, 2025 at 12:07 AM
PCP has pt on 4 agents for sleep/RLS…has never checked iron…ferritin of 6…what are we doing chat
Reposted by Heme Queen
🚨Abstract submissions for EAHAD 2026 are now open! Share your research with leading experts in haemophilia and bleeding disorders before 27 October ➡️
September 2, 2025 at 6:01 AM
🚨Abstract submissions for EAHAD 2026 are now open! Share your research with leading experts in haemophilia and bleeding disorders before 27 October ➡️
Reposted by Heme Queen
Pass the hematology boards with flying colors! 💫
Join the ASH Hematology Review Series for expert lectures and live sessions until October 6. Enroll today: https://bit.ly/3RR5bCN
#ABIM #HemeSky #MedSky #BoardExamsPrep
Join the ASH Hematology Review Series for expert lectures and live sessions until October 6. Enroll today: https://bit.ly/3RR5bCN
#ABIM #HemeSky #MedSky #BoardExamsPrep
August 22, 2025 at 1:00 PM
Pass the hematology boards with flying colors! 💫
Join the ASH Hematology Review Series for expert lectures and live sessions until October 6. Enroll today: https://bit.ly/3RR5bCN
#ABIM #HemeSky #MedSky #BoardExamsPrep
Join the ASH Hematology Review Series for expert lectures and live sessions until October 6. Enroll today: https://bit.ly/3RR5bCN
#ABIM #HemeSky #MedSky #BoardExamsPrep
Interested in a mentor to guide your career in malignant hematology? Apply for the ASH’s new Mentorship Program, and grow your network! Deadline: Sept 26. Apply today! 🔗 https://bit.ly/3IPWjMA
Interested in becoming a mentor? Sign up today: https://bit.ly/3U5tm1t
#HemeSky
Interested in becoming a mentor? Sign up today: https://bit.ly/3U5tm1t
#HemeSky
August 1, 2025 at 9:59 PM
Reposted by Heme Queen
Good news! The Senate’s leadership is proposing a $400M NIH funding increase for FY26. Now ASH urges the House to support the Senate numbers. ASH can’t do it alone—join the #Fight4Hematology: call, email, or meet with your Rep today. 🔗 https://bit.ly/3YeapvY
August 1, 2025 at 6:02 PM
Good news! The Senate’s leadership is proposing a $400M NIH funding increase for FY26. Now ASH urges the House to support the Senate numbers. ASH can’t do it alone—join the #Fight4Hematology: call, email, or meet with your Rep today. 🔗 https://bit.ly/3YeapvY
Reposted by Heme Queen
Interested in a mentor to guide your career in malignant hematology? Apply for the ASH’s new Mentorship Program, and grow your network! Deadline: Sept 26. Apply today! 🔗 https://bit.ly/3IPWjMA
Interested in becoming a mentor? Sign up today: https://bit.ly/3U5tm1t
#HemeSky
Interested in becoming a mentor? Sign up today: https://bit.ly/3U5tm1t
#HemeSky
July 31, 2025 at 6:30 PM
Interested in a mentor to guide your career in malignant hematology? Apply for the ASH’s new Mentorship Program, and grow your network! Deadline: Sept 26. Apply today! 🔗 https://bit.ly/3IPWjMA
Interested in becoming a mentor? Sign up today: https://bit.ly/3U5tm1t
#HemeSky
Interested in becoming a mentor? Sign up today: https://bit.ly/3U5tm1t
#HemeSky
So impressed at the increased support the American Society of Hematology is planning for trainees and early-career investigators!! At some point, someone invested in us. Now it’s our turn. #Fight4Hematology and secure the future of hematology research. Donate! #hemesky www.hematology.org/foundation
ASH Foundation
The ASH Foundation is dedicated to moving hematology forward through charitable support for ASH programs – helping hematologists conquer blood diseases worldwide.
www.hematology.org
July 31, 2025 at 2:35 PM
So impressed at the increased support the American Society of Hematology is planning for trainees and early-career investigators!! At some point, someone invested in us. Now it’s our turn. #Fight4Hematology and secure the future of hematology research. Donate! #hemesky www.hematology.org/foundation
Reposted by Heme Queen
💡An exciting illustrated review of "Gene-based therapies for hemophilia," by Wolfgang Miesbach et al is now available as full-OA article in @isth.org @rpth.bsky.social!
It provides a compreh. overview of #genetherapy for #hemophilia A & B, highlighting recent advances in patient care.
bit.ly/40RHmQ8
It provides a compreh. overview of #genetherapy for #hemophilia A & B, highlighting recent advances in patient care.
bit.ly/40RHmQ8
Gene-based therapies for hemophilia
Gene therapy is a transformative approach to treating genetic disorders in order to
improve disease outcomes for patients. Hemophilia A and B are inherited genetic disorders
caused by mutations in the...
bit.ly
July 17, 2025 at 4:02 PM
💡An exciting illustrated review of "Gene-based therapies for hemophilia," by Wolfgang Miesbach et al is now available as full-OA article in @isth.org @rpth.bsky.social!
It provides a compreh. overview of #genetherapy for #hemophilia A & B, highlighting recent advances in patient care.
bit.ly/40RHmQ8
It provides a compreh. overview of #genetherapy for #hemophilia A & B, highlighting recent advances in patient care.
bit.ly/40RHmQ8
Reposted by Heme Queen
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review.
https://ja.ma/4krNDZU
Learn more in this Review.
https://ja.ma/4krNDZU
July 5, 2025 at 2:00 PM
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review.
https://ja.ma/4krNDZU
Learn more in this Review.
https://ja.ma/4krNDZU
Reposted by Heme Queen
Meta-analysis on GLP-1RA (vs. placebo) and VTE:
🔹 PE rates significantly lower 📉
🔹 VTE rates lower but not statistically significant
🔹 No difference in DVT
🔹 Study design matters: RCTs vs. observational data
Accepted for publication in JTH!
#ISTH2025 #VTE #GLP1RA #Thrombosis
@jthjournal.bsky.social
🔹 PE rates significantly lower 📉
🔹 VTE rates lower but not statistically significant
🔹 No difference in DVT
🔹 Study design matters: RCTs vs. observational data
Accepted for publication in JTH!
#ISTH2025 #VTE #GLP1RA #Thrombosis
@jthjournal.bsky.social
June 23, 2025 at 7:43 PM
Meta-analysis on GLP-1RA (vs. placebo) and VTE:
🔹 PE rates significantly lower 📉
🔹 VTE rates lower but not statistically significant
🔹 No difference in DVT
🔹 Study design matters: RCTs vs. observational data
Accepted for publication in JTH!
#ISTH2025 #VTE #GLP1RA #Thrombosis
@jthjournal.bsky.social
🔹 PE rates significantly lower 📉
🔹 VTE rates lower but not statistically significant
🔹 No difference in DVT
🔹 Study design matters: RCTs vs. observational data
Accepted for publication in JTH!
#ISTH2025 #VTE #GLP1RA #Thrombosis
@jthjournal.bsky.social
Reposted by Heme Queen
This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!
Practice changing investigator-initiated RCT.
#ISTH2025
Practice changing investigator-initiated RCT.
#ISTH2025
June 22, 2025 at 1:49 PM
This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!
Practice changing investigator-initiated RCT.
#ISTH2025
Practice changing investigator-initiated RCT.
#ISTH2025
June 23, 2025 at 3:15 PM
Reposted by Heme Queen
Why is managing hypertensive disorders during pregnancy challenging? Tune in with Drs. Richard Burwick and Shruti Chaturvedi for a new HemeTalks episode for insights on pre-eclampsia, diagnostic tests, and management strategies! 🎧 https://bit.ly/3XwnXCD
#HemeSky @ash.edu.hematology.org
#HemeSky @ash.edu.hematology.org
June 19, 2025 at 7:00 PM
Why is managing hypertensive disorders during pregnancy challenging? Tune in with Drs. Richard Burwick and Shruti Chaturvedi for a new HemeTalks episode for insights on pre-eclampsia, diagnostic tests, and management strategies! 🎧 https://bit.ly/3XwnXCD
#HemeSky @ash.edu.hematology.org
#HemeSky @ash.edu.hematology.org
Reposted by Heme Queen
Why do some people with the Duffy null phenotype have an ANC below most institutional reference ranges? Explore the mechanism behind this phenomenon 👇
Learn more: www.hematology.org/e...
#DuffyNull #HemeSky #MedSky #DANC #ASHEducation @ash.edu.hematology.org
Learn more: www.hematology.org/e...
#DuffyNull #HemeSky #MedSky #DANC #ASHEducation @ash.edu.hematology.org
May 20, 2025 at 4:52 PM
Why do some people with the Duffy null phenotype have an ANC below most institutional reference ranges? Explore the mechanism behind this phenomenon 👇
Learn more: www.hematology.org/e...
#DuffyNull #HemeSky #MedSky #DANC #ASHEducation @ash.edu.hematology.org
Learn more: www.hematology.org/e...
#DuffyNull #HemeSky #MedSky #DANC #ASHEducation @ash.edu.hematology.org
Reposted by Heme Queen
Platelet refractoriness describes a poor response to platelet transfusion, and conventional thinking has divided etiologies into 2 broad categories: immune and nonimmune. buff.ly/JEfMzzB #hemesky #transfusionmedicine #HowITreat
May 21, 2025 at 1:03 PM
Platelet refractoriness describes a poor response to platelet transfusion, and conventional thinking has divided etiologies into 2 broad categories: immune and nonimmune. buff.ly/JEfMzzB #hemesky #transfusionmedicine #HowITreat
Reposted by Heme Queen
#ASHSlideSaturday 🩸: Examine the slide from the #ASHImageBank. Identify the cells and where you may see them.
Tune in tomorrow for the answer!
#ASHEducation #Microlearning #MedEd #Hemesky #Hematology #Hematologist #MedicalEducation #TIL
Tune in tomorrow for the answer!
#ASHEducation #Microlearning #MedEd #Hemesky #Hematology #Hematologist #MedicalEducation #TIL
May 10, 2025 at 12:01 PM
#ASHSlideSaturday 🩸: Examine the slide from the #ASHImageBank. Identify the cells and where you may see them.
Tune in tomorrow for the answer!
#ASHEducation #Microlearning #MedEd #Hemesky #Hematology #Hematologist #MedicalEducation #TIL
Tune in tomorrow for the answer!
#ASHEducation #Microlearning #MedEd #Hemesky #Hematology #Hematologist #MedicalEducation #TIL
Reposted by Heme Queen
The entire CDC lead program has been eliminated.
Lead exposure can lead to many issues including anemia & irreversible brain damage in young children.
It was <10 years ago we learned that 99,000 people in Flint Michigan had been exposed.
If only eliminating programs eliminated the risk.
Lead exposure can lead to many issues including anemia & irreversible brain damage in young children.
It was <10 years ago we learned that 99,000 people in Flint Michigan had been exposed.
If only eliminating programs eliminated the risk.
April 11, 2025 at 8:31 PM
The entire CDC lead program has been eliminated.
Lead exposure can lead to many issues including anemia & irreversible brain damage in young children.
It was <10 years ago we learned that 99,000 people in Flint Michigan had been exposed.
If only eliminating programs eliminated the risk.
Lead exposure can lead to many issues including anemia & irreversible brain damage in young children.
It was <10 years ago we learned that 99,000 people in Flint Michigan had been exposed.
If only eliminating programs eliminated the risk.
Mild neutropenia may not need a bone marrow biopsy….
DANC can be diagnosed with just a quick easy blood test!
DANC can be diagnosed with just a quick easy blood test!
What is Duffy null-associated neutrophil count (DANC) and how to discuss it with patients?
Follow a patient conversation to review DANC's epidemiology, biology, and impact on healthcare in this e-module.
🔗 https://bit.ly/4iatW7K
#DuffyNull #HemeSky #MedSky #DANC @ash.edu.hematology.org
Follow a patient conversation to review DANC's epidemiology, biology, and impact on healthcare in this e-module.
🔗 https://bit.ly/4iatW7K
#DuffyNull #HemeSky #MedSky #DANC @ash.edu.hematology.org
April 11, 2025 at 7:02 PM
Mild neutropenia may not need a bone marrow biopsy….
DANC can be diagnosed with just a quick easy blood test!
DANC can be diagnosed with just a quick easy blood test!
Reposted by Heme Queen
Now the D-team has chainsawed the CDC Division of Blood Diseases...
Thanks @ash.hematology.org 90+ other organizations for speaking up!
This action has immediate harms to the health of Americans.
www.medpagetoday.com/hematologyon...
Thanks @ash.hematology.org 90+ other organizations for speaking up!
This action has immediate harms to the health of Americans.
www.medpagetoday.com/hematologyon...
Groups Demand RFK Jr. 'Immediately' Restore CDC's Axed Blood Division
ASH, others warn of preventable hospitalizations and deaths for Americans with blood disorders
www.medpagetoday.com
April 9, 2025 at 8:21 PM
Now the D-team has chainsawed the CDC Division of Blood Diseases...
Thanks @ash.hematology.org 90+ other organizations for speaking up!
This action has immediate harms to the health of Americans.
www.medpagetoday.com/hematologyon...
Thanks @ash.hematology.org 90+ other organizations for speaking up!
This action has immediate harms to the health of Americans.
www.medpagetoday.com/hematologyon...